Skip to main content

ARF and RHD
Guidelines

RHD Australia

Administering Bicillin Video Launched

Monday, June 1, 2015

A collaboration between the Queensland Rheumatic Heart Disease Control Program and RHDAustralia produces a video for clinicians and health workers who give intramuscular (IM) Bicillin  injections to prevent acute rheumatic fever. With funding coming from an educational grant from Pfizer Australia, this instructional video supports health care professionals who deliver regular Bicillin injections to people with rheumatic fever and rheumatic heart disease.

The video includes an introduction to rheumatic fever and rheumatic heart disease, a section of the physiology of normal heart valves and damaged (rheumatic) heart valves, the role of Bicillin in preventing recurrent rheumatic fever, identification of common intramuscular injection sites and demonstration of injection methods and strategies to minimise pain, stress and inconvenience that can be associated with injections.

To prevent acute rheumatic fever recurrence, secondary prophylaxis with bicillin (BPG) is required. It is given as an intramuscular (IM) injection. This video is presented in 5 sections: 

  1. Introduction
  2. Physiology 
  3. Treatment 
  4. IM injection site and methods 
  5. Reducing pain, stress and inconvenience. (This video is the basis for the eLearning module which is available on the RHDAustralia e-learning platform) 

As of November 2019, the video has over 13,000 views and is the most popular video resource on the RHDAustralia website.

Please see the corresponding Injection sites and methods - Information flyer, a one page flyer about BPG injection administration. To prevent acute rheumatic fever recurrence, secondary prophylaxis with benzathine penicillin G (BPG) is required. BPG given as an intramuscular (IM) injection. This can be stressful and inconvenient, and the injections can be painful. It is important to identify any hurdles the patient might experience and develop strategies to overcome them, to ensure patients come back for this regular ongoing treatment.

Video 

RHDAustralia since 2009

Rheumatic Heart Disease Australia is an initiative of Menzies School of Health Research and is funded by the Commonwealth Government. Since 2009, RHDAustralia has been working with health professionals and alongside Aboriginal and Torres Strait Islander peoples, and other at risk populations, to reduce acute rheumatic fever and rheumatic heart disease in Australia.